1. ZHAW digitalcollection
  2. School of Management and Law
  3. Publikationen
  4. Publikationen School of Management and Law
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJoeris, Alexander-
dc.contributor.authorHöglinger, Marc-
dc.contributor.authorMeier, Flurina-
dc.contributor.authorKnöfler, Fabio-
dc.contributor.authorScholz, Stefan-
dc.contributor.authorBrügger, Urs-
dc.contributor.authorDenk, Eberhard-
dc.contributor.authorGutzwiller, Felix-
dc.contributor.authorPrein, Joachim-
dc.contributor.authorRenner, Nikolaus-
dc.contributor.authorEichler, Klaus-
dc.date.accessioned2022-12-20T13:21:59Z-
dc.date.available2022-12-20T13:21:59Z-
dc.date.issued2019-
dc.identifier.issn1098-3015de_CH
dc.identifier.issn1524-4733de_CH
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/26469-
dc.description.abstractObjectives: After the inception of the AO Foundation in1958, fracture osteosynthesis (OS) was introduced in Switzerland and in the following 2 to 3 decade globally. OS has revolutionized fracture care. However, there has never been a formal impact evaluation of OS as a medical innovation. It was the aim to estimate the health economic impact of OS in fracture care for three index bones over 60 years in 17 high-income countries. Methods: A modelling approach using a decision tree was applied for this cost comparison study. To do so, a (hypothetical) absence of the OS technology was presumed and OS (intervention) was compared with conservative treatment (CONS; comparator) from a societal perspective. We included fracture patients with femur, tibia and radius fractures (age ,65yr.); for proximal femur fractures elderly patients ($70yr.) were also included. Outcomes were differences between OS and CONS in years of life gained (YLG), direct and indirect costs (2015 Swiss Francs for all modelled years; discount rate 3%). We used data from the Swiss Accident Insurance, OECD and World Bank. From our base case Switzerland, we extrapolated our results to 16 other high-income countries from four continents (Europe, North America, Asia, Australia) and performed sensitivity analyses. Results: In the working age population, CHF 855 bn. (sensitivity analysis: min. CHF 360 bn. to max. CHF 1213 bn.) were saved in direct and indirect costs over 6 decades in 17 countries for femur, tibia and radius fractures. 4.6 million YLG were gained in this age group (2/3 of them before age 65 and included in indirect costs). In the elderly population with proximal femur fractures, CHF 69 bn. were saved in direct costs in addition to 73 million YLG. Conclusions: The health economic impact of OS was substantial over six decades. It resulted important productivity gains and YLG.de_CH
dc.language.isoende_CH
dc.publisherElsevierde_CH
dc.relation.ispartofValue in Healthde_CH
dc.rightsLicence according to publishing contractde_CH
dc.subjectOsteosynthesisde_CH
dc.subjectHealth economicsde_CH
dc.subject.ddc362.1041: Gesundheitsökonomiede_CH
dc.titleHealth economic impact of the technology “osteosynthesis” on fracture care : an economic analysis for 17 high income countries over the course of 60 yearsde_CH
dc.typeKonferenz: Sonstigesde_CH
dcterms.typeTextde_CH
zhaw.departementSchool of Management and Lawde_CH
zhaw.organisationalunitWinterthurer Institut für Gesundheitsökonomie (WIG)de_CH
dc.identifier.doi10.1016/j.jval.2019.04.1010de_CH
zhaw.conference.detailsISPOR 2019 Annual Conference, New Orleans, USA, 18-22 May 2019de_CH
zhaw.funding.euNode_CH
zhaw.issueSupplement 2de_CH
zhaw.originated.zhawYesde_CH
zhaw.pages.startS218de_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.volume22de_CH
zhaw.publication.reviewPeer review (Abstract)de_CH
zhaw.author.additionalNode_CH
zhaw.display.portraitYesde_CH
Appears in collections:Publikationen School of Management and Law

Files in This Item:
There are no files associated with this item.
Show simple item record
Joeris, A., Höglinger, M., Meier, F., Knöfler, F., Scholz, S., Brügger, U., Denk, E., Gutzwiller, F., Prein, J., Renner, N., & Eichler, K. (2019). Health economic impact of the technology “osteosynthesis” on fracture care : an economic analysis for 17 high income countries over the course of 60 years [Conference presentation]. Value in Health, 22(Supplement 2), S218. https://doi.org/10.1016/j.jval.2019.04.1010
Joeris, A. et al. (2019) ‘Health economic impact of the technology “osteosynthesis” on fracture care : an economic analysis for 17 high income countries over the course of 60 years’, in Value in Health. Elsevier, p. S218. Available at: https://doi.org/10.1016/j.jval.2019.04.1010.
A. Joeris et al., “Health economic impact of the technology “osteosynthesis” on fracture care : an economic analysis for 17 high income countries over the course of 60 years,” in Value in Health, 2019, vol. 22, no. Supplement 2, p. S218. doi: 10.1016/j.jval.2019.04.1010.
JOERIS, Alexander, Marc HÖGLINGER, Flurina MEIER, Fabio KNÖFLER, Stefan SCHOLZ, Urs BRÜGGER, Eberhard DENK, Felix GUTZWILLER, Joachim PREIN, Nikolaus RENNER und Klaus EICHLER, 2019. Health economic impact of the technology “osteosynthesis” on fracture care : an economic analysis for 17 high income countries over the course of 60 years. In: Value in Health. Conference presentation. Elsevier. 2019. S. S218
Joeris, Alexander, Marc Höglinger, Flurina Meier, Fabio Knöfler, Stefan Scholz, Urs Brügger, Eberhard Denk, et al. 2019. “Health Economic Impact of the Technology “Osteosynthesis” on Fracture Care : An Economic Analysis for 17 High Income Countries over the Course of 60 Years.” Conference presentation. In Value in Health, 22:S218. Elsevier. https://doi.org/10.1016/j.jval.2019.04.1010.
Joeris, Alexander, et al. “Health Economic Impact of the Technology “Osteosynthesis” on Fracture Care : An Economic Analysis for 17 High Income Countries over the Course of 60 Years.” Value in Health, vol. 22, no. Supplement 2, Elsevier, 2019, p. S218, https://doi.org/10.1016/j.jval.2019.04.1010.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.